NCT00003375
Clinical Trial Information
Trial Number: NCT00003375 (ClinicalTrials.gov)
Disease Type:
- CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
- CNS Neoplasm (Primary Tumor) - Oligodendroglial Tumors
Trial Title:
A PHASE II STUDY OF OBSERVATION IN FAVORABLE LOW-GRADE GLIOMA AND A PHASE III STUDY OF RADIATION WITH OR WITHOUT PCV CHEMOTHERAPY IN UNFAVORABLE LOW-GRADE GLIOMA
Study ID:
RTOG 9802
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00003375-D3 | This dataset, NCT00003375-D3, contains from the NRG/RTOG-98-02 secondary publication PMID 32706640, supplementary table 3, which provides a comprehensive genomic analysis of the trial. There are two other datasets containing data from PMID 32706640. |
| NCT00003375-D2 | This dataset, NCT00003375-D2, contains the data from the NRG/RTOG-98-02 secondary publication PMID 32706640, supplementary table 2, which provides a comprehensive genomic analysis of the trial. There are two other datasets containing data from PMID 32706640. |
| NCT00003375-D1 | This dataset, NCT00003375-D1, contains the outcome and select genomic data from the NRG/RTOG-98-02 secondary publication PMID 32706640, which provides a comprehensive genomic analysis of the trial. There are two other datasets containing data from PMID 32706640. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®